Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: a link to protection against atherosclerosis?

Clin Biochem. 2009 Jun;42(9):791-5. doi: 10.1016/j.clinbiochem.2009.02.005. Epub 2009 Feb 13.

Abstract

Objective: To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS).

Design and methods: The soluble forms of CD40 ligand (sCD40L) and P-selectin (sP-selectin), and high sensitive C reactive protein (hs-CRP) levels were investigated in subjects with GS (n=25) and compared to healthy controls (n=53).

Results: sCD40L and hs-CRP levels were significantly lower in GS compared to the controls (0.33+/-0.27 vs 0.71+/-0.37 ng/mL, p<0.001 and 0.51+/-0.45 vs 1.16+/-1.31 mg/L, p=0.046, respectively). Both sCD40L and hs-CRP were negatively correlated with total bilirubin (r=-0.5, p<0.001 and r=-0.34, p=0.002, respectively). sP-selectin levels were lower in GS when compared to the controls but the difference did not reach statistical significance (p=0.052). No correlation was found between the plasma levels of sCD40L, sP-selectin and hs-CRP.

Conclusion: These novel findings suggest that reduced sCD40L and hs-CRP concentrations may have a role in the mechanism of protection against atherosclerosis in GS.

MeSH terms

  • Adult
  • Atherosclerosis / blood*
  • Atherosclerosis / prevention & control*
  • C-Reactive Protein / metabolism
  • CD40 Ligand / blood*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Gilbert Disease / blood*
  • Humans
  • Male
  • P-Selectin / blood*
  • Young Adult

Substances

  • P-Selectin
  • CD40 Ligand
  • C-Reactive Protein